Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Michaelson

Showing results (121-130 of 134) with videos related to

Pageof 14
Sort By:
Mabs|January 12, 2010
Anti-tumor activity of stability-engineered IgG-like bispecific antibodies targeting TRAIL-R2 and LTbetaRJennifer S Michaelson, Stephen J Demarest, Brian Miller, et al.
Archives of Pathology & Laboratory Medicine|August 30, 2014
Computational pathology: an emerging definitionDavid N Louis, Georg K Gerber, Jason M Baron, et al.
Cancer|September 24, 2004
The age at which women begin mammographic screeningJames A Colbert, Emily M Kaine, Judyann Bigby, et al.
Journal for Immunotherapy of Cancer|March 15, 2022
A novel IgG-based FLT3xCD3 bispecific antibody for the treatment of AML and B-ALLNaveen K Mehta, Martin Pfluegler, Kristan Meetze, et al.
Journal for Immunotherapy of Cancer|February 4, 2026
Dysregulated expression of the tumor suppressor p14ARF in cancer provides an effective target for TCR-T cell therapeuticsThomas M Schmitt, Kelsey Furiya, Cheryl Black, et al.
The EMBO Journal|November 25, 2006
TWEAK, via its receptor Fn14, is a novel regulator of mesenchymal progenitor cells and skeletal muscle regenerationMahasweta Girgenrath, Shawn Weng, Christine A Kostek, et al.
Cancer Research|October 5, 2006
Increased fibroblast growth factor-inducible 14 expression levels promote glioma cell invasion via Rac1 and nuclear factor-kappaB and correlate with poor patient outcomeNhan L Tran, Wendy S McDonough, Benjamin A Savitch, et al.
Journal of Pathology Informatics|January 6, 2016
Prediction of primary breast cancer size and T-stage using micro-computed tomography in lumpectomy specimensWafa M Sarraj, Rong Tang, Anas L Najjar, et al.
Circulation|April 8, 2009
A novel role for tumor necrosis factor-like weak inducer of apoptosis (TWEAK) in the development of cardiac dysfunction and failureMohit Jain, Aniela Jakubowski, Lei Cui, et al.
Annals of Surgical Oncology|June 7, 2007
Liver-directed surgery for metastatic squamous cell carcinoma to the liver: results of a multi-center analysisTimothy M Pawlik, Ana Luiza Gleisner, Todd W Bauer, et al.
Pageof 14

Showing results (121-130 of 134) with videos related to

Sort By:
Pageof 14
Mabs|January 12, 2010
Anti-tumor activity of stability-engineered IgG-like bispecific antibodies targeting TRAIL-R2 and LTbetaRJennifer S Michaelson, Stephen J Demarest, Brian Miller, et al.
Archives of Pathology & Laboratory Medicine|August 30, 2014
Computational pathology: an emerging definitionDavid N Louis, Georg K Gerber, Jason M Baron, et al.
Cancer|September 24, 2004
The age at which women begin mammographic screeningJames A Colbert, Emily M Kaine, Judyann Bigby, et al.
Journal for Immunotherapy of Cancer|March 15, 2022
A novel IgG-based FLT3xCD3 bispecific antibody for the treatment of AML and B-ALLNaveen K Mehta, Martin Pfluegler, Kristan Meetze, et al.
Journal for Immunotherapy of Cancer|February 4, 2026
Dysregulated expression of the tumor suppressor p14ARF in cancer provides an effective target for TCR-T cell therapeuticsThomas M Schmitt, Kelsey Furiya, Cheryl Black, et al.
The EMBO Journal|November 25, 2006
TWEAK, via its receptor Fn14, is a novel regulator of mesenchymal progenitor cells and skeletal muscle regenerationMahasweta Girgenrath, Shawn Weng, Christine A Kostek, et al.
Cancer Research|October 5, 2006
Increased fibroblast growth factor-inducible 14 expression levels promote glioma cell invasion via Rac1 and nuclear factor-kappaB and correlate with poor patient outcomeNhan L Tran, Wendy S McDonough, Benjamin A Savitch, et al.
Journal of Pathology Informatics|January 6, 2016
Prediction of primary breast cancer size and T-stage using micro-computed tomography in lumpectomy specimensWafa M Sarraj, Rong Tang, Anas L Najjar, et al.
Circulation|April 8, 2009
A novel role for tumor necrosis factor-like weak inducer of apoptosis (TWEAK) in the development of cardiac dysfunction and failureMohit Jain, Aniela Jakubowski, Lei Cui, et al.
Annals of Surgical Oncology|June 7, 2007
Liver-directed surgery for metastatic squamous cell carcinoma to the liver: results of a multi-center analysisTimothy M Pawlik, Ana Luiza Gleisner, Todd W Bauer, et al.
Pageof 14